Brind.
  1. AmbioPharm and CordenPharma are leveraging an acquisition to bolster U.S. peptide manufacturing capabilities, utilizing facilities in South Carolina and adding capacity in Shanghai.

CordenPharma has appointed Jean-Luc Herbeaux as CEO and successfully acquired AmbioPharm.

3 reports, 1 independent Updated Sep 15
Gone quiet Reached 3 outlets in its first 24 hours
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

CordenPharma has appointed Jean-Luc Herbeaux as CEO and successfully acquired AmbioPharm.

Keep exploring

Part of

AmbioPharm and CordenPharma are leveraging an acquisition to bolster U.S. peptide manufacturing capabilities, utilizing facilities in South Carolina and adding capacity in Shanghai. All 1 developments

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story